Brion Raymond | Chief Commercial Officer |
Charles Deignan | CFO & Secretary |
Daniel White | Founder, President, CEO & Director |
Glenn Noronha | Chief Scientific Officer |
Stephen Kilmer | IR |
Thomas Ciulla | Chief Medical Officer |
François Brisebois | Laidlaw & Company |
Nicholas Rubino | Stifel, Nicolaus |
Serge Belanger | Needham & Company |
Tessa Romero | JP Morgan |
Good day, ladies and gentlemen, and welcome to the Clearside Biomedical Inc.
Third Quarter 2018 Financial Results and Corporate Update Call. [Operator Instructions] As a reminder, today's conference may be recorded. I would now like to turn the call over to Stephen Kilmer, Clearside Investor Relations. Sir, you may begin.